Director Deals - (GSK)

Luke Miels, Chief Executive Officer, has re-invested 3 shares in the company on the 8th January 2026 at a price of £18.94. The Director now holds 3 shares representing 0.00% of the shares in issue.

Story provided by StockMarketWire.com

Director deals data provided by www.sharesmagazine.co.uk

< Back to list